Daré Bioscience, Inc. (DARE)
USD 3.18
(-0.31%)
USD 3.18
(-0.31%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -38.85 Million | -18.08 Million | -28.76 Million | -25.23 Million | -13.31 Million | -10.26 Million |
| Net Income | -30.16 Million | -30.94 Million | -38.69 Million | -27.4 Million | -14.26 Million | -16.73 Million |
| Depreciation & Amortization | 38.36 Thousand | 24.2 Thousand | 26.41 Thousand | 43.22 Thousand | 11.13 Thousand | 2440.00 |
| Deferred income taxes | -495.86 Thousand | - | -369.88 Thousand | - | - | - |
| Stock-based compensation | 2.53 Million | 2.15 Million | 1.59 Million | 742.03 Thousand | 462.23 Thousand | 139.34 Thousand |
| Change in working capital | -11.34 Million | 10.69 Million | 8.72 Million | 1.54 Million | 706.19 Thousand | 634.08 Thousand |
| Other non-cash items | 574.17 Thousand | -23.06 Thousand | -51.84 Thousand | -162.16 Thousand | -231.21 Thousand | 5.69 Million |
| Investing Cash Flow | -629.43 Thousand | -63.06 Thousand | -14.52 Thousand | -17.62 Thousand | 6.14 Million | -518.83 Thousand |
| Investments in PPE | -629.43 Thousand | -63.06 Thousand | -14.52 Thousand | -17.62 Thousand | - | -11.83 Thousand |
| Acquisitions | - | 925 Million | 925 Million | - | 6.14 Million | -507 Thousand |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | -925 Million | -925 Million | - | 6.14 Billion | -506.99 Thousand |
| Financing Cash Flow | 15.63 Million | 1.34 Million | 75.84 Million | 25.13 Million | 5.15 Million | 10.11 Million |
| Debt repayment | -4.99 Million | - | - | -367.28 Thousand | - | - |
| Dividends payments | - | - | - | -6.86 Million | -789.59 Million | - |
| Common Stock Repurchased | - | - | - | -367.28 Thousand | - | - |
| Common Stock Issuance | 10.64 Million | 1.21 Million | 75.31 Million | 22.97 Million | 5.15 Million | 10.11 Million |
| Other Financing Activities | 4.72 Million | 124.6 Thousand | 532.67 Thousand | 9.75 Million | 789.59 Million | 10.11 Million |
| Accounts receivables | 753.94 Thousand | -557.84 Thousand | -685.14 Thousand | 95.04 Thousand | -201.42 Thousand | 253.16 Thousand |
| Accounts payables | 1.35 Million | -75.13 Thousand | 1.08 Million | -61.85 Thousand | 608.65 Thousand | 151.48 Thousand |
| Inventory | - | 557.84 Thousand | 685.14 Thousand | -95.04 Thousand | 201.42 Thousand | - |
| Other working capital | -13.45 Million | 10.77 Million | 7.64 Million | 1.6 Million | 97.54 Thousand | 482.59 Thousand |
| Cash at beginning of period | 34.66 Million | 51.67 Million | 4.66 Million | 4.78 Million | 6.8 Million | 7.55 Million |
| Cash at end of period | 10.47 Million | 34.66 Million | 51.67 Million | 4.66 Million | 4.78 Million | 6.8 Million |
| Capital Expenditure | -629.43 Thousand | -63.06 Thousand | -14.52 Thousand | -17.62 Thousand | - | -11.83 Thousand |
| Effect of forex changes on cash | -9585.00 | -196.33 Thousand | -63.58 Thousand | 11.23 Thousand | -5897.00 | -78.64 Thousand |
| Net cash flow / Change in cash | -24.19 Million | -17 Million | 47 Million | -110.64 Thousand | -2.02 Million | -753.95 Thousand |
| Free Cash Flow | -39.48 Million | -18.15 Million | -28.77 Million | -25.25 Million | -13.31 Million | -10.28 Million |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -6.75 Million | -5.05 Million | -30.16 Million | -8.29 Million | -8.76 Million | -8.04 Million |
| Depreciation & Amortization | 10.77 Thousand | 9980.00 | 38.36 Thousand | 9260.00 | 9615.00 | 9508.00 |
| Deferred income taxes | - | -2.06 Million | -495.86 Thousand | - | - | - |
| Stock-based compensation | 627.7 Thousand | 619.79 Thousand | 2.53 Million | 636.08 Thousand | 650.18 Thousand | 624.62 Thousand |
| Change in working capital | -1.5 Million | -3.84 Million | -11.34 Million | -518.49 Thousand | 1.52 Million | -8.7 Million |
| Other non-cash items | 1.23 Million | 2.15 Million | 574.17 Thousand | 198.41 Thousand | -5905.00 | -5906.00 |
| Investing Cash Flow | -7296.00 | -607.33 Thousand | -629.43 Thousand | -22.09 Thousand | - | - |
| Investments in PPE | -7296.00 | -607.33 Thousand | -629.43 Thousand | -22.09 Thousand | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 21.7 Thousand | 5.3 Million | 15.63 Million | 8.57 Million | 452.19 Thousand | 1.29 Million |
| Debt repayment | -193.4 Thousand | -4.52 Million | -4.99 Million | -467.58 Thousand | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 215.11 Thousand | 785.76 Thousand | 10.64 Million | 8.1 Million | 452.19 Thousand | 1.29 Million |
| Other Financing Activities | -690.00 | 5.5 Million | 4.72 Million | 935.16 Thousand | 452.19 Thousand | 1.29 Million |
| Accounts receivables | -436.46 Thousand | 180.54 Thousand | 753.94 Thousand | -557.29 Thousand | 1.82 Million | -695.54 Thousand |
| Accounts payables | 654.95 Thousand | -1.6 Million | 1.35 Million | -1.55 Million | 3.84 Million | 667.66 Thousand |
| Inventory | - | - | - | 557.29 Thousand | -1.82 Million | 695.54 Thousand |
| Other working capital | -1.72 Million | -2.42 Million | -13.45 Million | 1.03 Million | -2.32 Million | -9.37 Million |
| Cash at beginning of period | 10.47 Million | 13.89 Million | 34.66 Million | 13.66 Million | 19.82 Million | 34.66 Million |
| Cash at end of period | 3.63 Million | 10.47 Million | 10.47 Million | 14.22 Million | 13.66 Million | 19.82 Million |
| Capital Expenditure | -7296.00 | -607.33 Thousand | -629.43 Thousand | -22.09 Thousand | - | - |
| Effect of forex changes on cash | -39.22 Thousand | 58.6 Thousand | -9585.00 | -15.02 Thousand | -31.15 Thousand | -22 Thousand |
| Net cash flow / Change in cash | -6.84 Million | -3.41 Million | -24.19 Million | 565.32 Thousand | -6.16 Million | -14.84 Million |
| Free Cash Flow | -6.82 Million | -8.78 Million | -39.48 Million | -7.99 Million | -6.58 Million | -16.11 Million |
CLPHF
SIEGY
BBXIA
FSGB
EMNSF
0ZNF